TNF and hematologic disorder: While LD can affect immunocompetent hosts, immunocompromised patients with solid tumors or hematological malignancies; solid organ transplants; or immunosuppressive medications such as tumor necrosis factor (TNF) inhibitors, corticosteroids, or antirejection medications are at increased risk [39].